InMed Pharmaceuticals Inc. INM
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.84M | -- | -2.03M | -1.73M | -1.79M |
| Total Depreciation and Amortization | 260.20K | -- | 158.00K | 156.70K | 128.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.85M | -- | 96.40K | 21.60K | -693.90K |
| Change in Net Operating Assets | 769.00K | -- | -602.40K | -59.00K | 242.60K |
| Cash from Operations | -2.96M | -- | -2.38M | -1.61M | -2.11M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Cash from Investing | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | -- | -- | -- | 3.77M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -- | 0.00 | -137.20K | 4.41M |
| Cash from Financing | 0.00 | -- | 0.00 | -137.20K | 8.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.96M | -- | -2.38M | -1.74M | 6.06M |